In a regulatory filing on Friday, Avery Dennison (AVY) noted that on November 14, Gregory Lovins, Senior Vice President and Chief Financial Officer of corporation, began a medical leave of absence. Lovins ceased serving as the company’s principal financial officer as of that date. On November 14, the company’s board elected Danny Allouche as the company’s Senior Vice President and Interim Chief Financial Officer, effective November 15. Allouche has served as the company’s Senior Vice President and Chief Strategy and Corporate Development Officer since August 2022, after having served as Vice President, Chief Strategy and Corporate Development Officer, from April 2021 to July 2022, the company noted. “Allouche will retain his current role as Chief Strategy and Corporate Development Officer in addition to assuming the responsibilities as the Company’s interim principal financial officer,” Avery Dennison stated.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVY:
- Avery Dennison Appoints Danny Allouche as Interim CFO
- Avery Dennison price target lowered to $25 from $28 at Barclays
- Avery Dennison price target lowered to $247 from $252 at BMO Capital
- Avery Dennison downgraded to Neutral from Overweight at JPMorgan
- Avery Dennison reports Q3 adjusted EPS $2.33, consensus $2.32